Jonathan Jassey
Adolescent Medicine · Roslyn, NYNPI 1689887705
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Pfizer at 47.8% of the total. Among adolescent medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 125 payments — averaging $247.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$15K
- Biomerieux Inc$13K
- Sekisui Diagnostics LLC$1K
- Corium, LLC$518
- Merck$174
- Supernus Pharmaceuticals, Inc.$163
- plus $1K from 25 others
What the payments were for
- Consulting fees$8,06726%
- Speaking & faculty fees$14,56047%
- Travel & lodging$3,68212%
- Food & beverage$3,41711%
- Education$110%
- Gifts$1,2274%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 21 | $14,809 |
| Biomerieux Inc | 13 | $12,719 |
| Sekisui Diagnostics LLC | 4 | $1,155 |
| Corium, LLC | 22 | $518 |
| Merck | 7 | $174 |
| Supernus Pharmaceuticals, Inc. | 5 | $163 |
| Aytu Biopharma, Inc. | 8 | $162 |
| Regeneron Healthcare Solutions, Inc. | 2 | $149 |
| Grifols USA, LLC | 6 | $143 |
| Alk-abello, Inc | 5 | $141 |
| GSK | 7 | $139 |
| VYNE Pharmaceuticals Inc. | 1 | $123 |
| Memed US, Inc. | 2 | $72 |
| Cranial Technologies, Inc | 3 | $54 |
| Verrica Pharmaceuticals Inc. | 2 | $50 |
| Cognoa, Inc. | 1 | $46 |
| Hikma Pharmaceuticals USA | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Blueprint Medicines Corporation | 1 | $28 |
| Novartis | 1 | $27 |
| Seqirus USA Inc | 1 | $25 |
| Incyte Corporation | 1 | $24 |
| Shire North American Group Inc | 1 | $22 |
| Kaleo, Inc. | 1 | $22 |
| Tris Pharma Inc | 1 | $20 |
| Phadia US Inc. | 1 | $19 |
| Neos Therapeutics, LP | 1 | $19 |
| Genentech USA, Inc. | 1 | $19 |
| LNHC, Inc | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EUCRISA$13,019
- BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel$6,065
- DUPIXENT$125
- AMZEEQ$123
How this compares
$30,964 in reported general payments places this provider in the 95th percentile of 257 adolescent medicine providers in New York.
Other adolescent medicine in Roslyn
- Melanie GoldNew York$61K
- Michelle Collins-OgleBronx$13K
- Katherine GreenbergRochester$9K
- Juan EspinozaBrentwood$8K
- Anne MosconaNew York$7K
- Chelikani VarmaDepew$6K
- Maureen CooneyNyack$6K
- Michael RosenbaumNew York$5K
- Joseph CalabroPoughkeepsie$5K
- Parvaneh BorojeniPoughkeepsie$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.